CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome
Authors
B.A. Fisher Jonsson, R. Daniels, T. Bombardieri, M. Brown, R.M. Morgan, P. Bombardieri, S. Ng, W.-F. Tzioufas, A.G. Vitali, C. Shirlaw, P. Haacke, E. Costa, S. Bootsma, H. Devauchelle-Pensec, V. Radstake, T.R. Mariette, X. Richards, A. Stack, R. Bowman, S.J. Barone, F. De Albuquerque, R.P.P. Allen, R. Astorri, E. Baldini, C. Bhabra, R. Brito-Zerón, P. Chengot, P. Fedele, S. Kruize, A.A. Omdal, R. Porter, S. Potts, J. Poveda-Gallego, A. Price, E. Priori, R. Ramos-Casals, M. Retamozo, S. Suchak, K. Sutcliffe, N. Syed, Z. Tappuni, A.R. Theander, E. Wahren-Herlenius, M. Triantafyllou, A. Vissink, A. De Vita, S. Yap, C. Osayi, K. Sjogren&apos
Publication date
1 January 2017
Publisher
Abstract
Labial salivary gland (LSG) biopsy is used in the classification of primary Sjögren's syndrome (PSS) and in patient stratification in clinical trials. It may also function as a biomarker. The acquisition of tissue and histological interpretation is variable and needs to be standardised for use in clinical trials. A modified European League Against Rheumatism consensus guideline development strategy was used. The steering committee of the ad hoc working group identified key outstanding points of variability in LSG acquisition and analysis. A 2-day workshop was held to develop consensus where possible and identify points where further discussion/data was needed. These points were reviewed by a subgroup of experts on PSS histopathology and then circulated via an online survey to 50 stakeholder experts consisting of rheumatologists, histopathologists and oral medicine specialists, to assess level of agreement (0-10 scale) and comments. Criteria for agreement were a mean score ≥6/10 and 75% of respondents scoring ≥6/10. Thirty-nine (78%) experts responded and 16 points met criteria for agreement. These points are focused on tissue requirements, identification of the characteristic focal lymphocytic sialadenitis, calculation of the focus score, identification of germinal centres, assessment of the area of leucocyte infiltration, reporting standards and use of prestudy samples for clinical trials. We provide standardised consensus guidance for the use of labial salivary gland histopathology in the classification of PSS and in clinical trials and identify areas where further research is required to achieve evidence-based consensus. © 2016 BMJ Publishing Group Limited
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3001057
Last time updated on 10/02/2023
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3001059
Last time updated on 10/02/2023